Herbas VPB

Print
EN | LT
LT - PEG-IFN-alfa ir ribavirino panaudojimas lėtinio hepatito C gydymui
EN - USE OF PEG-IFN-ALPHA AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C

Legal status

Patent expired

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/70 (2006.01)
A61K 31/7056 (2006.01)
A61K 38/21 (2006.01)
A61K 47/48 (2006.01)
A61P 1/16 (2006.01)
A61P 31/12 (2006.01)
A61P 31/14 (2006.01)
A61P 43/00 (2006.01)
European patent
(11) Number of the document 1087778
(13) Kind of document T
(96) European patent application number 99927804.7
Date of filing the European patent application 1999-05-29
(97) Date of publication of the European application 2001-04-04
(45) Date of publication and mention of the grant of the patent 2005-10-26
(46) Date of publication of the claims translation 2006-02-27
PCT application
(86) Number PCT/EP1999/003746
Date 1999-05-29
PCT application publication
(87) Number WO 1999/064016
Date 1999-12-16
Priority applications
(30) Number Date Country code
98110433 1998-06-08 EP
Inventors
(72)
ZAHM, Friederike, DE
Grantee
(73) F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, CH
Attorney or representative
(74) Marius JAKULIS - JASON, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) PEG-IFN-alfa ir ribavirino panaudojimas lėtinio hepatito C gydymui
  USE OF PEG-IFN-ALPHA AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C
Last renewal fee
Payment date Validity (years) Amount
2018-05-21 20 347.00 EUR